Reduction in FeNO on anti-IL5 biologics is associated with clinical remission of severe asthma
Marianne Baastrup Soendergaard(Frederiksberg Hospital), Celeste Porsbjerg(Bispebjerg Hospital), Susanne Hansen(Bispebjerg Hospital), Charlotte Suppli Ulrik(Hvidovre Hospital), Johannes Martin Schmid(Aarhus University Hospital), Claus Rikard Johnsen(Gentofte Hospital), Anne‐Sofie Bjerrum(Aarhus University Hospital), Anna von Bülow(Frederiksberg Hospital), Kjell Erik Julius Haakansson(Hvidovre Hospital), Ole Hilberg(Lillebaelt Hospital)
Cited by 0
Related Papers
Eosinophilic and Noneosinophilic Asthma
|CHEST Journal|2021|262
Clinical Response and Remission in Patients With Severe Asthma Treated With Biologic Therapies
|CHEST Journal|2023|139
Importance of genetic factors in the etiology of atopic dermatitis: A twin study
|Allergy and Asthma Proceedings|2007|131